Loading...

Cosmo Pharmaceuticals N.V.

CMOPF•PNK
Healthcare
Drug Manufacturers - General
$118.50
$3.66(3.19%)
U.S. Market opens in NaNh NaNm

Cosmo Pharmaceuticals N.V. (CMOPF) Stock Overview

Explore Cosmo Pharmaceuticals N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.9B
P/E Ratio-446.99
EPS (TTM)$-0.26
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$129.58
3 Months$89.69
1 Year Target$112.39

CMOPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cosmo Pharmaceuticals N.V. (CMOPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $112.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -446.99 and a market capitalization of 1.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.19%
5-Day Change
-0.47%
1-Month Change
15.82%
3-Month Change
-21.79%
6-Month Change
42.69%
Year-to-Date (YTD) Change
-10.90%
1-Year Change
115.45%
3-Year Change
90.21%
5-Year Change
19.70%
All-Time (Max) Change
-26.25%

Contact Information

https://www.cosmopharma.com
353 1 817 0370
Riverside II, Dublin, NaN, 2

Company Facts

321 Employees
IPO DateJul 31, 2017
CountryIE
Actively Trading

Frequently Asked Questions